Boston Scientific Corp
BSX98.180USD
+0.040+0.04%
Cierre 09/26, 16:00（ET）Cotizaciones retrasadas 15 min
145.34BCap. mercado
58.02P/E TTM
Más Datos de Compañía
Información de la empresa
Símbolo de cotizaciónBSX
Nombre de la empresaBoston Scientific Corp
Fecha de salida a bolsaMay 19, 1992
Director ejecutivoMr. Michael F. (Mike) Mahoney
Número de empleados53000
Tipo de seguridadOrdinary Share
Fin del año fiscalMay 19
Dirección300 Boston Scientific Way
CiudadMARLBOROUGH
Bolsa de valoresNYSE Consolidated
PaísUnited States of America
Código postal01752-1234
Teléfono15086834000
Sitio Webhttps://www.bostonscientific.com/en-US/Home.html
Símbolo de cotizaciónBSX
Fecha de salida a bolsaMay 19, 1992
Director ejecutivoMr. Michael F. (Mike) Mahoney
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Michael F. (Mike) Mahoney
Mr. Michael F. (Mike) Mahoney
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.75M
-3.25%
Mr. John E. Sununu
Mr. John E. Sununu
Independent Director
Independent Director
54.72K
+3.95%
Mr. David S. (Dave) Wichmann
Mr. David S. (Dave) Wichmann
Independent Director
Independent Director
41.58K
+5.27%
Ms. Ellen M. Zane
Ms. Ellen M. Zane
Independent Director
Independent Director
37.02K
+5.96%
Mr. Jonathan R. Monson
Mr. Jonathan R. Monson
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
35.29K
+1.62%
Mr. Vance R. Brown
Mr. Vance R. Brown
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
33.45K
+6.64%
Mr. David C. Habiger
Mr. David C. Habiger
Independent Director
Independent Director
5.63K
+58.67%
Mr. Yoshiaki Fujimori
Mr. Yoshiaki Fujimori
Independent Director
Independent Director
2.08K
-58.23%
Mr. Arthur Crosswell Butcher
Mr. Arthur Crosswell Butcher
Executive Vice President, Group President, MedSurg and Asia Pacific
Executive Vice President, Group President, MedSurg and Asia Pacific
--
--
Mr. Edward J. Ludwig
Mr. Edward J. Ludwig
Lead Independent Director
Lead Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Michael F. (Mike) Mahoney
Mr. Michael F. (Mike) Mahoney
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.75M
-3.25%
Mr. John E. Sununu
Mr. John E. Sununu
Independent Director
Independent Director
54.72K
+3.95%
Mr. David S. (Dave) Wichmann
Mr. David S. (Dave) Wichmann
Independent Director
Independent Director
41.58K
+5.27%
Ms. Ellen M. Zane
Ms. Ellen M. Zane
Independent Director
Independent Director
37.02K
+5.96%
Mr. Jonathan R. Monson
Mr. Jonathan R. Monson
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
35.29K
+1.62%
Mr. Vance R. Brown
Mr. Vance R. Brown
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
33.45K
+6.64%
Desglose de ingresos
Divisa: USDActualizado: dom., 6 de jul
Divisa: USDActualizado: dom., 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
Electrophysiology
730.00M
15.66%
Interventional Cardiology Therapies
697.00M
14.95%
Endoscopy
673.00M
14.43%
Peripheral Interventions
656.00M
14.07%
Urology
633.00M
13.57%
Otro
1.27B
27.32%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
2.96B
63.48%
EMEA (Europe, Middle East and Africa)
846.00M
18.14%
Asia Pacific
701.00M
15.03%
Latin America and Canada
155.00M
3.32%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Electrophysiology
730.00M
15.66%
Interventional Cardiology Therapies
697.00M
14.95%
Endoscopy
673.00M
14.43%
Peripheral Interventions
656.00M
14.07%
Urology
633.00M
13.57%
Otro
1.27B
27.32%
Estadísticas de accionistas
Actualizado: sáb., 16 de ago
Actualizado: sáb., 16 de ago
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
9.21%
Fidelity Management & Research Company LLC
6.71%
BlackRock Institutional Trust Company, N.A.
5.28%
State Street Global Advisors (US)
4.40%
PRIMECAP Management Company
2.34%
Otro
72.06%
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
9.21%
Fidelity Management & Research Company LLC
6.71%
BlackRock Institutional Trust Company, N.A.
5.28%
State Street Global Advisors (US)
4.40%
PRIMECAP Management Company
2.34%
Otro
72.06%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
51.04%
Investment Advisor/Hedge Fund
29.03%
Hedge Fund
4.14%
Pension Fund
2.73%
Research Firm
2.53%
Bank and Trust
2.05%
Sovereign Wealth Fund
1.54%
Family Office
0.23%
Private Equity
0.21%
Otro
6.51%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
2752
1.39B
93.57%
+165.36K
2025Q1
2744
1.39B
93.81%
-5.31M
2024Q4
2559
1.38B
93.61%
+1.09M
2024Q3
2417
1.37B
92.76%
-24.32M
2024Q2
2341
1.37B
93.29%
-18.17M
2024Q1
2227
1.37B
93.23%
-40.14M
2023Q4
2171
1.39B
94.95%
-25.34M
2023Q3
2110
1.39B
95.17%
-6.29M
2023Q2
2081
1.38B
95.67%
-15.63M
2023Q1
2012
1.36B
94.85%
-23.81M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
The Vanguard Group, Inc.
133.95M
9.05%
+1.70M
+1.28%
Mar 31, 2025
Fidelity Management & Research Company LLC
117.45M
7.94%
-3.75M
-3.09%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
77.81M
5.26%
+1.08M
+1.41%
Mar 31, 2025
State Street Global Advisors (US)
64.48M
4.36%
+514.79K
+0.80%
Mar 31, 2025
PRIMECAP Management Company
36.50M
2.47%
-432.72K
-1.17%
Mar 31, 2025
Wellington Management Company, LLP
33.20M
2.24%
-2.97M
-8.21%
Mar 31, 2025
Geode Capital Management, L.L.C.
31.80M
2.15%
+1.18M
+3.84%
Mar 31, 2025
Capital World Investors
28.56M
1.93%
+658.82K
+2.36%
Mar 31, 2025
Managed Account Advisors LLC
21.29M
1.44%
+3.60M
+20.36%
Mar 31, 2025
The Bollard Group, LLC
20.49M
1.39%
-242.40K
-1.17%
Mar 31, 2025
Ver más
ETFs relacionados
Actualizado: mar., 2 de sep
Actualizado: mar., 2 de sep
Nombre
Proporción
iShares U.S. Medical Devices ETF
10.54%
Goldman Sachs Future Health Care Equity ETF
8.82%
Invesco Dorsey Wright Healthcare Momentum ETF
4.98%
JPMorgan Healthcare Leaders ETF
4.19%
Global X Aging Population ETF
3.18%
iShares U.S. Healthcare ETF
3.16%
Knowledge Leaders Developed World ETF
3.16%
Proshares Ultra Health Care
3.15%
Bancreek U.S. Large Cap ETF
3.14%
Health Care Select Sector SPDR Fund
3.1%
Ver más
iShares U.S. Medical Devices ETF
Proporción10.54%
Goldman Sachs Future Health Care Equity ETF
Proporción8.82%
Invesco Dorsey Wright Healthcare Momentum ETF
Proporción4.98%
JPMorgan Healthcare Leaders ETF
Proporción4.19%
Global X Aging Population ETF
Proporción3.18%
iShares U.S. Healthcare ETF
Proporción3.16%
Knowledge Leaders Developed World ETF
Proporción3.16%
Proshares Ultra Health Care
Proporción3.15%
Bancreek U.S. Large Cap ETF
Proporción3.14%
Health Care Select Sector SPDR Fund
Proporción3.1%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
